First Experience of Robotic-assisted Percutaneous Coronary Intervention in Japan

In 2018, the CorPath GRX system (Corindus) was approved for use in Japan, marking the introduction of the first robotic-assisted system for percutaneous coronary intervention (PCI) in the country. The present report describes the first experience of robotic-assisted PCI for four coronary lesions in...

Descripción completa

Detalles Bibliográficos
Autores principales: Kagiyama, Koutaro, Ueno, Takafumi, Mitsutake, Yoshiaki, Yamaji, Kazunori, Ishimatsu, Takashi, Sasaki, Ken-ichiro, Fukumoto, Yoshihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6928489/
https://www.ncbi.nlm.nih.gov/pubmed/31366804
http://dx.doi.org/10.2169/internalmedicine.3272-19
Descripción
Sumario:In 2018, the CorPath GRX system (Corindus) was approved for use in Japan, marking the introduction of the first robotic-assisted system for percutaneous coronary intervention (PCI) in the country. The present report describes the first experience of robotic-assisted PCI for four coronary lesions in two cases in a single center. All procedures succeeded without any complications, although one procedure was converted to manual PCI by the operator’s decision. Post-marketing surveillance to assess the impact of this novel system on both Japanese patients and physicians is currently ongoing in Japan.

Ejemplares similares